Literature DB >> 16316597

Pathogenic role of nitric oxide alterations in diabetic nephropathy.

Sharma S Prabhakar1.   

Abstract

Diabetic nephropathy is the most frequent cause of terminal renal failure, requiring renal replacement therapy. Although a number of factors may contribute to the development of renal disease in diabetes, the recent past has witnessed an explosive growth in literature pertaining to the role of nitric oxide in diabetic nephropathy. However, there are significant controversies in the findings of these studies partly because of the complex metabolic pathways involved in the generation and fate of nitric oxide in the diabetic kidney. The following discussion presents a critical and balanced review of the current understanding of this subject.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16316597     DOI: 10.1007/s11892-005-0054-8

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  49 in total

1.  Increased expression of endothelial cell nitric oxide synthase (ecNOS) in afferent and glomerular endothelial cells is involved in glomerular hyperfiltration of diabetic nephropathy.

Authors:  H Sugimoto; K Shikata; M Matsuda; M Kushiro; Y Hayashi; K Hiragushi; J Wada; H Makino
Journal:  Diabetologia       Date:  1998-12       Impact factor: 10.122

2.  Nitric oxide synthesis and isoprostane production in subjects with type 1 diabetes and normal urinary albumin excretion.

Authors:  S O'Byrne; P Forte; L J Roberts; J D Morrow; A Johnston; E Anggård; R D Leslie; N Benjamin
Journal:  Diabetes       Date:  2000-05       Impact factor: 9.461

3.  NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy.

Authors:  Minoru Satoh; Sohachi Fujimoto; Yoshisuke Haruna; Sayaka Arakawa; Hideyuki Horike; Norio Komai; Tamaki Sasaki; Katsuhiko Tsujioka; Hirofumi Makino; Naoki Kashihara
Journal:  Am J Physiol Renal Physiol       Date:  2005-02-01

4.  Renal nitric oxide production during the early phase of experimental diabetes mellitus.

Authors:  S Keynan; B Hirshberg; N Levin-Iaina; I D Wexler; R Dahan; E Reinhartz; H Ovadia; Y Wollman; T Chernihovskey; A Iaina; I Raz
Journal:  Kidney Int       Date:  2000-08       Impact factor: 10.612

Review 5.  From hyperglycemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines.

Authors:  Bieke F Schrijvers; An S De Vriese; Allan Flyvbjerg
Journal:  Endocr Rev       Date:  2004-12       Impact factor: 19.871

6.  Inhibition of nitric oxide synthase activity by early and advanced glycation end products in cultured rabbit proximal tubular epithelial cells.

Authors:  P Verbeke; M Perichon; B Friguet; H Bakala
Journal:  Biochim Biophys Acta       Date:  2000-11-15

7.  Renal nitric oxide production is decreased in diabetic rats and improved by AT1 receptor blockade.

Authors:  Alaa S Awad; Randy L Webb; Robert M Carey; Helmy M Siragy
Journal:  J Hypertens       Date:  2004-08       Impact factor: 4.844

8.  Nitric oxide modulates the synthesis of extracellular matrix proteins in cultured rat mesangial cells.

Authors:  H Trachtman; S Futterweit; P Singhal
Journal:  Biochem Biophys Res Commun       Date:  1995-02-06       Impact factor: 3.575

9.  L-arginine administration prevents glomerular hyperfiltration and decreases proteinuria in diabetic rats.

Authors:  A A Reyes; I E Karl; J Kissane; S Klahr
Journal:  J Am Soc Nephrol       Date:  1993-10       Impact factor: 10.121

10.  Enhanced expression of inducible nitric oxide synthase in murine macrophages and glomerular mesangial cells by elevated glucose levels: possible mediation via protein kinase C.

Authors:  K Sharma; T M Danoff; A DePiero; F N Ziyadeh
Journal:  Biochem Biophys Res Commun       Date:  1995-02-06       Impact factor: 3.575

View more
  5 in total

1.  Assessment of renal fibrosis in murine diabetic nephropathy using quantitative magnetization transfer MRI.

Authors:  Feng Wang; Daisuke Katagiri; Ke Li; Keiko Takahashi; Suwan Wang; Shinya Nagasaka; Hua Li; C Chad Quarles; Ming-Zhi Zhang; Akira Shimizu; John C Gore; Raymond C Harris; Takamune Takahashi
Journal:  Magn Reson Med       Date:  2018-05-30       Impact factor: 4.668

2.  Mapping murine diabetic kidney disease using chemical exchange saturation transfer MRI.

Authors:  Feng Wang; David Kopylov; Zhongliang Zu; Keiko Takahashi; Suwan Wang; C Chad Quarles; John C Gore; Raymond C Harris; Takamune Takahashi
Journal:  Magn Reson Med       Date:  2015-11-26       Impact factor: 4.668

3.  Association between genetic polymorphisms of ACE & eNOS and diabetic nephropathy.

Authors:  P Huo; D Zhang; X Guan; Y Mei; H Zheng; X Feng
Journal:  Mol Biol Rep       Date:  2014-09-17       Impact factor: 2.316

Review 4.  Mind the gap: connexins and cell-cell communication in the diabetic kidney.

Authors:  Claire E Hills; Gareth W Price; Paul E Squires
Journal:  Diabetologia       Date:  2014-10-31       Impact factor: 10.122

5.  Genetic Targeting of Arginase-II in Mouse Prevents Renal Oxidative Stress and Inflammation in Diet-Induced Obesity.

Authors:  Ji Huang; Angana Rajapakse; Yuyan Xiong; Jean-Pierre Montani; François Verrey; Xiu-Fen Ming; Zhihong Yang
Journal:  Front Physiol       Date:  2016-11-22       Impact factor: 4.566

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.